UCL INSTITUTE OF OPHTHALMOLOGY
DIVISION OF MOLECULAR THERAPY
UCL homepageUCL Logo
Text size Small textMedium textLarge text
White text on Black
Black text on White
Funding
funding

The group has received funding from The Sir Jules Thorn Charitable Trust, The Medical Research Council, Foundation Fighting Blindness (USA), Wellcome Trust, Fight for Sight, British Retinitis Pigmentosa Society, The Royal Society, Frost Trust, European Union, Royal College of Surgeons of Edinburgh, The Health Foundation, National Institute for Health Research, Fighting Blindness Ireland and has industrial sponsorship from Oxford Biomedica, Ark Therapeutics and Sangamo BioSciences.


Medical Research Council (MRC)
www.mrc.ac.uk

The Wellcome Trust
www.wellcome.ac.uk

Department of Health
www.dh.gov.uk

The Royal College of Surgeons of Edinburgh
www.rcsed.ac.uk

The Sir Jules Thorn Charitable Trust
www.julesthorntrust.org.uk/

The Health Foundation
www.health.org.uk/

Clingene
www.clinigene.eu/

EVI-Genoret
www.evi-genoret.org/

British Retinitis Pigmentosa Society (BRPS)
www.brps.org.uk

Fight for Sight
www.fightforsight.org.uk

The Royal Society
www.royalsoc.ac.uk

National Institute for Health Research
www.nihr.ac.uk/Pages/default.aspx

 

 

This page last modified 18 December, 2012 by xxx


University College London - Gower Street - London - WC1E 6BT - Telephone: +44 (0)20 7679 2000 - Copyright © 1999-2007 UCL


Search by Google